0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Chronic Intestinal Inflammation Treatment Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-24N14015
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Chronic Intestinal Inflammation Treatment Drug Market Research Report 2023
BUY CHAPTERS

Chronic Intestinal Inflammation Treatment Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-24N14015
Report
October 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Chronic Intestinal Inflammation Treatment Drug - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Chronic Intestinal Inflammation Treatment Drug - Market

Chronic Intestinal Inflammation Treatment Drug - Market

The global market for Chronic Intestinal Inflammation Treatment Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chronic Intestinal Inflammation Treatment Drug, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Chronic Intestinal Inflammation Treatment Drug by region & country, by Type, and by Application.
The Chronic Intestinal Inflammation Treatment Drug market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Intestinal Inflammation Treatment Drug.
Market Segmentation

Scope of Chronic Intestinal Inflammation Treatment Drug - Market Report

Report Metric Details
Report Name Chronic Intestinal Inflammation Treatment Drug - Market
CAGR 5%
Segment by Type:
  • Amino-salicylates
  • Antibiotics
  • Corticosteroids
  • Immunomodulators
  • Biologics
  • Others
Segment by Application
  • Ulcerative Colitis
  • Crohns Disease
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Biocon Ltd, Roche, Johnson and Johnson, Mylan Pharmaceuticals, Novartis AG, Pfizer, Quest Medical, Sanofi, Takeda Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Chronic Intestinal Inflammation Treatment Drug manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Chronic Intestinal Inflammation Treatment Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Chronic Intestinal Inflammation Treatment Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Chronic Intestinal Inflammation Treatment Drug - Market report?

Ans: The main players in the Chronic Intestinal Inflammation Treatment Drug - Market are Abbott Laboratories, Biocon Ltd, Roche, Johnson and Johnson, Mylan Pharmaceuticals, Novartis AG, Pfizer, Quest Medical, Sanofi, Takeda Pharmaceutical

What are the Application segmentation covered in the Chronic Intestinal Inflammation Treatment Drug - Market report?

Ans: The Applications covered in the Chronic Intestinal Inflammation Treatment Drug - Market report are Ulcerative Colitis, Crohns Disease, Others

What are the Type segmentation covered in the Chronic Intestinal Inflammation Treatment Drug - Market report?

Ans: The Types covered in the Chronic Intestinal Inflammation Treatment Drug - Market report are Amino-salicylates, Antibiotics, Corticosteroids, Immunomodulators, Biologics, Others

1 Market Overview
1.1 Chronic Intestinal Inflammation Treatment Drug Product Introduction
1.2 Global Chronic Intestinal Inflammation Treatment Drug Market Size Forecast
1.3 Chronic Intestinal Inflammation Treatment Drug Market Trends & Drivers
1.3.1 Chronic Intestinal Inflammation Treatment Drug Industry Trends
1.3.2 Chronic Intestinal Inflammation Treatment Drug Market Drivers & Opportunity
1.3.3 Chronic Intestinal Inflammation Treatment Drug Market Challenges
1.3.4 Chronic Intestinal Inflammation Treatment Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Chronic Intestinal Inflammation Treatment Drug Players Revenue Ranking (2023)
2.2 Global Chronic Intestinal Inflammation Treatment Drug Revenue by Company (2019-2024)
2.3 Key Companies Chronic Intestinal Inflammation Treatment Drug Manufacturing Base Distribution and Headquarters
2.4 Key Companies Chronic Intestinal Inflammation Treatment Drug Product Offered
2.5 Key Companies Time to Begin Mass Production of Chronic Intestinal Inflammation Treatment Drug
2.6 Chronic Intestinal Inflammation Treatment Drug Market Competitive Analysis
2.6.1 Chronic Intestinal Inflammation Treatment Drug Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Chronic Intestinal Inflammation Treatment Drug Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Intestinal Inflammation Treatment Drug as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Amino-salicylates
3.1.2 Antibiotics
3.1.3 Corticosteroids
3.1.4 Immunomodulators
3.1.5 Biologics
3.1.6 Others
3.2 Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Type
3.2.1 Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Chronic Intestinal Inflammation Treatment Drug Sales Value, by Type (2019-2030)
3.2.3 Global Chronic Intestinal Inflammation Treatment Drug Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Ulcerative Colitis
4.1.2 Crohns Disease
4.1.3 Others
4.2 Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Application
4.2.1 Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Chronic Intestinal Inflammation Treatment Drug Sales Value, by Application (2019-2030)
4.2.3 Global Chronic Intestinal Inflammation Treatment Drug Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Region
5.1.1 Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Region (2019-2024)
5.1.3 Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Region (2025-2030)
5.1.4 Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Chronic Intestinal Inflammation Treatment Drug Sales Value, 2019-2030
5.2.2 North America Chronic Intestinal Inflammation Treatment Drug Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Chronic Intestinal Inflammation Treatment Drug Sales Value, 2019-2030
5.3.2 Europe Chronic Intestinal Inflammation Treatment Drug Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Chronic Intestinal Inflammation Treatment Drug Sales Value, 2019-2030
5.4.2 Asia Pacific Chronic Intestinal Inflammation Treatment Drug Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Chronic Intestinal Inflammation Treatment Drug Sales Value, 2019-2030
5.5.2 South America Chronic Intestinal Inflammation Treatment Drug Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Chronic Intestinal Inflammation Treatment Drug Sales Value, 2019-2030
5.6.2 Middle East & Africa Chronic Intestinal Inflammation Treatment Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Chronic Intestinal Inflammation Treatment Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Chronic Intestinal Inflammation Treatment Drug Sales Value
6.3 United States
6.3.1 United States Chronic Intestinal Inflammation Treatment Drug Sales Value, 2019-2030
6.3.2 United States Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Chronic Intestinal Inflammation Treatment Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Chronic Intestinal Inflammation Treatment Drug Sales Value, 2019-2030
6.4.2 Europe Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Chronic Intestinal Inflammation Treatment Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Chronic Intestinal Inflammation Treatment Drug Sales Value, 2019-2030
6.5.2 China Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China Chronic Intestinal Inflammation Treatment Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Chronic Intestinal Inflammation Treatment Drug Sales Value, 2019-2030
6.6.2 Japan Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Chronic Intestinal Inflammation Treatment Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Chronic Intestinal Inflammation Treatment Drug Sales Value, 2019-2030
6.7.2 South Korea Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Chronic Intestinal Inflammation Treatment Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Chronic Intestinal Inflammation Treatment Drug Sales Value, 2019-2030
6.8.2 Southeast Asia Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Chronic Intestinal Inflammation Treatment Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Chronic Intestinal Inflammation Treatment Drug Sales Value, 2019-2030
6.9.2 India Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India Chronic Intestinal Inflammation Treatment Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
7.1.4 Abbott Laboratories Chronic Intestinal Inflammation Treatment Drug Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Biocon Ltd
7.2.1 Biocon Ltd Profile
7.2.2 Biocon Ltd Main Business
7.2.3 Biocon Ltd Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
7.2.4 Biocon Ltd Chronic Intestinal Inflammation Treatment Drug Revenue (US$ Million) & (2019-2024)
7.2.5 Biocon Ltd Recent Developments
7.3 Roche
7.3.1 Roche Profile
7.3.2 Roche Main Business
7.3.3 Roche Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
7.3.4 Roche Chronic Intestinal Inflammation Treatment Drug Revenue (US$ Million) & (2019-2024)
7.3.5 Johnson and Johnson Recent Developments
7.4 Johnson and Johnson
7.4.1 Johnson and Johnson Profile
7.4.2 Johnson and Johnson Main Business
7.4.3 Johnson and Johnson Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
7.4.4 Johnson and Johnson Chronic Intestinal Inflammation Treatment Drug Revenue (US$ Million) & (2019-2024)
7.4.5 Johnson and Johnson Recent Developments
7.5 Mylan Pharmaceuticals
7.5.1 Mylan Pharmaceuticals Profile
7.5.2 Mylan Pharmaceuticals Main Business
7.5.3 Mylan Pharmaceuticals Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
7.5.4 Mylan Pharmaceuticals Chronic Intestinal Inflammation Treatment Drug Revenue (US$ Million) & (2019-2024)
7.5.5 Mylan Pharmaceuticals Recent Developments
7.6 Novartis AG
7.6.1 Novartis AG Profile
7.6.2 Novartis AG Main Business
7.6.3 Novartis AG Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
7.6.4 Novartis AG Chronic Intestinal Inflammation Treatment Drug Revenue (US$ Million) & (2019-2024)
7.6.5 Novartis AG Recent Developments
7.7 Pfizer
7.7.1 Pfizer Profile
7.7.2 Pfizer Main Business
7.7.3 Pfizer Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
7.7.4 Pfizer Chronic Intestinal Inflammation Treatment Drug Revenue (US$ Million) & (2019-2024)
7.7.5 Pfizer Recent Developments
7.8 Quest Medical
7.8.1 Quest Medical Profile
7.8.2 Quest Medical Main Business
7.8.3 Quest Medical Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
7.8.4 Quest Medical Chronic Intestinal Inflammation Treatment Drug Revenue (US$ Million) & (2019-2024)
7.8.5 Quest Medical Recent Developments
7.9 Sanofi
7.9.1 Sanofi Profile
7.9.2 Sanofi Main Business
7.9.3 Sanofi Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
7.9.4 Sanofi Chronic Intestinal Inflammation Treatment Drug Revenue (US$ Million) & (2019-2024)
7.9.5 Sanofi Recent Developments
7.10 Takeda Pharmaceutical
7.10.1 Takeda Pharmaceutical Profile
7.10.2 Takeda Pharmaceutical Main Business
7.10.3 Takeda Pharmaceutical Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
7.10.4 Takeda Pharmaceutical Chronic Intestinal Inflammation Treatment Drug Revenue (US$ Million) & (2019-2024)
7.10.5 Takeda Pharmaceutical Recent Developments
8 Industry Chain Analysis
8.1 Chronic Intestinal Inflammation Treatment Drug Industrial Chain
8.2 Chronic Intestinal Inflammation Treatment Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Chronic Intestinal Inflammation Treatment Drug Sales Model
8.5.2 Sales Channel
8.5.3 Chronic Intestinal Inflammation Treatment Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Chronic Intestinal Inflammation Treatment Drug Market Trends
    Table 2. Chronic Intestinal Inflammation Treatment Drug Market Drivers & Opportunity
    Table 3. Chronic Intestinal Inflammation Treatment Drug Market Challenges
    Table 4. Chronic Intestinal Inflammation Treatment Drug Market Restraints
    Table 5. Global Chronic Intestinal Inflammation Treatment Drug Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Chronic Intestinal Inflammation Treatment Drug Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Chronic Intestinal Inflammation Treatment Drug Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Chronic Intestinal Inflammation Treatment Drug Product Type
    Table 9. Key Companies Time to Begin Mass Production of Chronic Intestinal Inflammation Treatment Drug
    Table 10. Global Chronic Intestinal Inflammation Treatment Drug Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Intestinal Inflammation Treatment Drug as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Chronic Intestinal Inflammation Treatment Drug Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Chronic Intestinal Inflammation Treatment Drug Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Chronic Intestinal Inflammation Treatment Drug Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Chronic Intestinal Inflammation Treatment Drug Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Region (2019-2024) & (%)
    Table 27. Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Chronic Intestinal Inflammation Treatment Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Chronic Intestinal Inflammation Treatment Drug Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Chronic Intestinal Inflammation Treatment Drug Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Laboratories Basic Information List
    Table 32. Abbott Laboratories Description and Business Overview
    Table 33. Abbott Laboratories Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Chronic Intestinal Inflammation Treatment Drug Business of Abbott Laboratories (2019-2024)
    Table 35. Abbott Laboratories Recent Developments
    Table 36. Biocon Ltd Basic Information List
    Table 37. Biocon Ltd Description and Business Overview
    Table 38. Biocon Ltd Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Chronic Intestinal Inflammation Treatment Drug Business of Biocon Ltd (2019-2024)
    Table 40. Biocon Ltd Recent Developments
    Table 41. Roche Basic Information List
    Table 42. Roche Description and Business Overview
    Table 43. Roche Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Chronic Intestinal Inflammation Treatment Drug Business of Roche (2019-2024)
    Table 45. Roche Recent Developments
    Table 46. Johnson and Johnson Basic Information List
    Table 47. Johnson and Johnson Description and Business Overview
    Table 48. Johnson and Johnson Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Chronic Intestinal Inflammation Treatment Drug Business of Johnson and Johnson (2019-2024)
    Table 50. Johnson and Johnson Recent Developments
    Table 51. Mylan Pharmaceuticals Basic Information List
    Table 52. Mylan Pharmaceuticals Description and Business Overview
    Table 53. Mylan Pharmaceuticals Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Chronic Intestinal Inflammation Treatment Drug Business of Mylan Pharmaceuticals (2019-2024)
    Table 55. Mylan Pharmaceuticals Recent Developments
    Table 56. Novartis AG Basic Information List
    Table 57. Novartis AG Description and Business Overview
    Table 58. Novartis AG Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Chronic Intestinal Inflammation Treatment Drug Business of Novartis AG (2019-2024)
    Table 60. Novartis AG Recent Developments
    Table 61. Pfizer Basic Information List
    Table 62. Pfizer Description and Business Overview
    Table 63. Pfizer Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Chronic Intestinal Inflammation Treatment Drug Business of Pfizer (2019-2024)
    Table 65. Pfizer Recent Developments
    Table 66. Quest Medical Basic Information List
    Table 67. Quest Medical Description and Business Overview
    Table 68. Quest Medical Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Chronic Intestinal Inflammation Treatment Drug Business of Quest Medical (2019-2024)
    Table 70. Quest Medical Recent Developments
    Table 71. Sanofi Basic Information List
    Table 72. Sanofi Description and Business Overview
    Table 73. Sanofi Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Chronic Intestinal Inflammation Treatment Drug Business of Sanofi (2019-2024)
    Table 75. Sanofi Recent Developments
    Table 76. Takeda Pharmaceutical Basic Information List
    Table 77. Takeda Pharmaceutical Description and Business Overview
    Table 78. Takeda Pharmaceutical Chronic Intestinal Inflammation Treatment Drug Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Chronic Intestinal Inflammation Treatment Drug Business of Takeda Pharmaceutical (2019-2024)
    Table 80. Takeda Pharmaceutical Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Chronic Intestinal Inflammation Treatment Drug Downstream Customers
    Table 84. Chronic Intestinal Inflammation Treatment Drug Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Chronic Intestinal Inflammation Treatment Drug Product Picture
    Figure 2. Global Chronic Intestinal Inflammation Treatment Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Chronic Intestinal Inflammation Treatment Drug Sales Value (2019-2030) & (US$ Million)
    Figure 4. Chronic Intestinal Inflammation Treatment Drug Report Years Considered
    Figure 5. Global Chronic Intestinal Inflammation Treatment Drug Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Chronic Intestinal Inflammation Treatment Drug Revenue in 2023
    Figure 7. Chronic Intestinal Inflammation Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Amino-salicylates Picture
    Figure 9. Antibiotics Picture
    Figure 10. Corticosteroids Picture
    Figure 11. Immunomodulators Picture
    Figure 12. Biologics Picture
    Figure 13. Others Picture
    Figure 14. Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Chronic Intestinal Inflammation Treatment Drug Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Product Picture of Ulcerative Colitis
    Figure 17. Product Picture of Crohns Disease
    Figure 18. Product Picture of Others
    Figure 19. Global Chronic Intestinal Inflammation Treatment Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 20. Global Chronic Intestinal Inflammation Treatment Drug Sales Value Market Share by Application, 2023 & 2030
    Figure 21. North America Chronic Intestinal Inflammation Treatment Drug Sales Value (2019-2030) & (US$ Million)
    Figure 22. North America Chronic Intestinal Inflammation Treatment Drug Sales Value by Country (%), 2023 VS 2030
    Figure 23. Europe Chronic Intestinal Inflammation Treatment Drug Sales Value (2019-2030) & (US$ Million)
    Figure 24. Europe Chronic Intestinal Inflammation Treatment Drug Sales Value by Country (%), 2023 VS 2030
    Figure 25. Asia Pacific Chronic Intestinal Inflammation Treatment Drug Sales Value (2019-2030) & (US$ Million)
    Figure 26. Asia Pacific Chronic Intestinal Inflammation Treatment Drug Sales Value by Country (%), 2023 VS 2030
    Figure 27. South America Chronic Intestinal Inflammation Treatment Drug Sales Value (2019-2030) & (US$ Million)
    Figure 28. South America Chronic Intestinal Inflammation Treatment Drug Sales Value by Country (%), 2023 VS 2030
    Figure 29. Middle East & Africa Chronic Intestinal Inflammation Treatment Drug Sales Value (2019-2030) & (US$ Million)
    Figure 30. Middle East & Africa Chronic Intestinal Inflammation Treatment Drug Sales Value by Country (%), 2023 VS 2030
    Figure 31. Key Countries/Regions Chronic Intestinal Inflammation Treatment Drug Sales Value (%), (2019-2030)
    Figure 32. United States Chronic Intestinal Inflammation Treatment Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 33. United States Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (%), 2023 VS 2030
    Figure 34. United States Chronic Intestinal Inflammation Treatment Drug Sales Value by Application (%), 2023 VS 2030
    Figure 35. Europe Chronic Intestinal Inflammation Treatment Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 36. Europe Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (%), 2023 VS 2030
    Figure 37. Europe Chronic Intestinal Inflammation Treatment Drug Sales Value by Application (%), 2023 VS 2030
    Figure 38. China Chronic Intestinal Inflammation Treatment Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 39. China Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (%), 2023 VS 2030
    Figure 40. China Chronic Intestinal Inflammation Treatment Drug Sales Value by Application (%), 2023 VS 2030
    Figure 41. Japan Chronic Intestinal Inflammation Treatment Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Japan Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (%), 2023 VS 2030
    Figure 43. Japan Chronic Intestinal Inflammation Treatment Drug Sales Value by Application (%), 2023 VS 2030
    Figure 44. South Korea Chronic Intestinal Inflammation Treatment Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 45. South Korea Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (%), 2023 VS 2030
    Figure 46. South Korea Chronic Intestinal Inflammation Treatment Drug Sales Value by Application (%), 2023 VS 2030
    Figure 47. Southeast Asia Chronic Intestinal Inflammation Treatment Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (%), 2023 VS 2030
    Figure 49. Southeast Asia Chronic Intestinal Inflammation Treatment Drug Sales Value by Application (%), 2023 VS 2030
    Figure 50. India Chronic Intestinal Inflammation Treatment Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 51. India Chronic Intestinal Inflammation Treatment Drug Sales Value by Type (%), 2023 VS 2030
    Figure 52. India Chronic Intestinal Inflammation Treatment Drug Sales Value by Application (%), 2023 VS 2030
    Figure 53. Chronic Intestinal Inflammation Treatment Drug Industrial Chain
    Figure 54. Chronic Intestinal Inflammation Treatment Drug Manufacturing Cost Structure
    Figure 55. Channels of Distribution (Direct Sales, and Distribution)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS